Skip to Content

Newsletters

Below you will find the various newsletters we have published, which provide important information about our immunotherapy kit.

APAVAC® autologous vaccination

Newsletter


APAVAC® autologous immunotherapy: useful and non-toxic in the treatment of equine melanoma

Newsletter - Case Report

Efficacy of APAVAC® immunotherapy in the adjuvant treatment of canine mucosal melanoma

Newsletter - case report


Carcinome intestinal mucineux canin et immunothérapie

Newsletter - case report


APAVAC® immunotherapy integrated into a multimodal strategy for the treatment of canine osteosarcoma

Newsletter - case report


Autologous therapeutic vaccine APAVAC®: Lymph node system role

Newsletter 


APAVAC® autologous therapeutic vaccine and TP53 gene

Newsletter 


immunotherapeutic strategie for canine lymphoma :

Newsletter 


The 3 keys to autologous immunotherapy APAVAC® (1. Tumor Antigens)

Newsletter


The 3 keys to autologous immunotherapy  APAVAC® (2. Heat Shock proteins)

Newsletter


The 3 keys to autologous immunotherapy  APAVAC® (3. Hydroxyapatite)

Newsletter